Neurodegeneration – Products

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers Squibb (NYSE: BMY).

This article reviews pathological and physiological role of Tau proteins in neurodegeneration, Tau-targeted drug development strategies, and SignalChem’s contribution

bit.bio, announces the launch of its ioTracker Cells range, starting with GFP ioMicroglia, a progressive tool designed to accelerate complex neurodegenerative disease research and drug discovery.

Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance.

Spear Bio Inc., announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs).

Oxford Nanopore Technologies, announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.

This whitepaper explores the translational and clinical applications of IMC to develop biomarkers and future treatment strategies in neuro-oncology and neurodegenerative studies.

This application note demonstrates how imaging mass cytometry (IMC) is transforming neurodegeneration research, providing detailed visualization of protein aggregates, neuron populations and inflammatory cell interactions.

Aneuro provides high-quality Tau products — proteins, fibrils, cell lines, and antibodies. These products assist researchers in investigating Tau's role in neurodegenerative diseases and developing potential therapies.